Clearbridge Investments, LLC

Position in PBH — Prestige Consumer Healthcare Inc.

CIK 1348883 NEW YORK, NY

Position in PBH

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$6,704,266

-$482,002 QoQ

Shares Held

113,114

-2.9% QoQ

Ownership

0.239%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 99.91336174125219.ToString("F0")% Shared 0.ToString("F0")% None 0.08663825874781193.ToString("F0")%

Healthcare · as of Mar 31, 2026

Clearbridge Investments, LLC holds $474,940,742 across 5 Drug Manufacturers - Specialty & Generic names. PBH ranks #4 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	31,718,725	$317,504,437
2	ELAN	Elanco Animal Health Inc	4,581,016	$109,623,712
3	NBIX	Neurocrine Biosciences Inc	310,035	$40,844,010
4	PBH	Prestige Consumer Healthcare Inc. This page	113,114	$6,704,266
5	ZTS	Zoetis Inc.	2,236	$264,317

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,704,266	113,114	-2.9%	Shares	Sole	2026-05-13
2025-12-31	$7,186,268	116,490	-8.1%	Shares	Sole	2026-02-11
2025-09-30	$7,906,704	126,710	+27.1%	Shares	Sole	2025-11-13
2025-06-30	$7,960,486	99,693	-38.5%	Shares	Sole	2025-08-12
2025-03-31	$13,944,505	162,202	-32.1%	Shares	Sole	2025-05-13
2024-12-31	$18,662,026	238,981	-0.1%	Shares	Sole	2025-02-12
2024-09-30	$17,245,022	239,182	-0.8%	Shares	Sole	2024-11-12
2024-06-30	$16,594,846	241,029	-2.0%	Shares	Sole	2024-08-27
2024-03-31	$17,846,494	245,955	-12.1%	Shares	Sole	2024-05-13
2023-12-31	$17,136,518	279,917	+0.6%	Shares	Sole	2024-02-09
2023-09-30	$15,915,748	278,296	-2.8%	Shares	Sole	2023-11-13
2023-06-30	$17,010,351	286,225	+13.7%	Shares	Sole	2023-08-11
2023-03-31	$15,773,177	251,847	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.